Distance Campuses

Orlando Campus

Erin L St. Onge

Erin L St. Onge Pharm.D.

Clinical Associate Professor

Dr. St. Onge joined the faculty in July 2002 to help start the University of Florida College of Pharmacy program in Orlando. As the Associate Campus Director for the Orlando campus, she devotes her time to her various roles as teacher, advisor, and administrator.

Dr. St. Onge graduated from the University of Florida College of Pharmacy with her Doctor of Pharmacy degree with honors in 1999. Upon graduation, she completed a residency in Community Clinical Pharmacy with St. Louis College of Pharmacy/Walgreens. Dr. St. Onge accepted her first faculty position with Texas Tech University School of Pharmacy at their Lubbock campus. During her two years with Texas Tech, she gained valuable experience with their 3-campus (Amarillo, Lubbock, Dallas) distance education program. Also, she developed a community site for 3rd and 4th year students, as well as a residency program in Community Clinical Pharmacy. Dr. St. Onge and her family moved to Orlando in summer of 2002 at which time she accepted the position as Campus Director for Orlando. Dr. St. Onge has practiced ambulatory care in a variety of settings. She currently holds a joint appointment with the University of Central Florida College of Medicine where she provides clinical pharmacy services to patients at UCF Health. Additionally, Dr. St. Onge is very involved with interprofessional education initiatives with several schools/colleges within the University of Central Florida (Medicine, Nursing, Social Work, Physical Therapy, etc). The group was recently awarded the inaugural IPEC/USPHS National Award for Excellence in Interprofessional Education for their efforts at a student/faculty run clinic in Apopka, Florida. In addition to her current position with UF College of Pharmacy, she is very active in national pharmacy organizations and has held numerous leadership positions in state and local pharmacy organizations. Dr. St. Onge’s interests include diabetes mellitus, cardiovascular disease, and women’s health.

Shannon A Miller

Shannon A Miller Pharm.D., BCACP

Clinical Associate Professor

Shannon Miller comes to UF from Florida Hospital, where she was a family medicine faculty member and an ambulatory care clinical pharmacist for 17 years. Miller received her Pharm.D. degree from the University of Florida College Of Pharmacy and completed a primary care residency at Florida Hospital in Orlando, FL. After residency, she created a faculty position within the family medicine residency and started numerous clinics including anticoagulation, diabetes, hypertension and asthma. Miller worked closely with the family medicine residents and was awarded Faculty of the Year in 2009 and 2010, Lecturer of the Year in 2002, and Outstanding Educator in 2000. While working as an ambulatory care pharmacist with Florida Hospital, she was named University of Florida Preceptor of the Year in 2001, 2003 and 2009.

Miller is a Board Certified Ambulatory Care Specialist. She currently practices in a multi-disciplinary geriatric clinic in Winter Park, Florida. Miller is a recipient of the University of Florida College of Pharmacy Outstanding Teaching Team Award in 2017 and 2018 and the University of Florida College of Pharmacy Teacher of the Year Award in 2018.

John M Allen

John M Allen Pharm.D., BCPS, BCCCP, FCCM

Clinical Assistant Professor

John M. Allen, Pharm.D., BCPS, BCCCP, FCCM is a clinical assistant professor at the University of Florida College of Pharmacy Orlando Campus. Born and raised in Philadelphia, Dr. Allen joined the College in 2018. Dr. Allen’s professional areas of interest include antimicrobial stewardship in the intensive care unit (ICU), sedation and analgesia in the critically ill, nutrition in the critically ill and strategies used to mitigate drug shortages in the ICU setting.

Dr. Allen graduated with his Doctor of Pharmacy degree from Florida A&M University in Tallahassee, FL. He then completed a PGY-1 residency, followed by a PGY-2 Critical Care residency at Tampa General Hospital, in Tampa, FL. Dr. Allen is a dual board-certified pharmacist in critical care, and pharmacotherapy.

Dr. Allen is an active member of the Society of Critical Care Medicine, American College of Clinical Pharmacy and the Florida Society of Health-System Pharmacists and has been appointed to committees within the three organizations. In 2017, Dr. Allen received the prestigious honor of induction as a Fellow of the American College of Critical Care Medicine, which honors individuals whose achievements and contributions demonstrate personal commitment to critical care excellence, a distinction at the time of his induction bestowed upon seven pharmacists in the state of Florida.

Prior to his appointment at the University of Florida, Dr. Allen has held a variety of diverse administrative experiences including serving as a pharmacy clinical coordinator, pharmacy residency program director, and director of infectious diseases pharmacy for a 16-hospital system. In his free time, Dr. Allen enjoys watching anything with four wheels going fast, traveling and spending time with his wife and three children.

Jürgen Bulitta

Jürgen Bulitta Ph.D.

Associate Professor

Jürgen B. Bulitta, PhD, is an Associate Professor in the Department of Pharmacotherapy and Translational Research at the UF College of Pharmacy. He is supported by the University of Florida’s pre-eminence program in Drug Discovery and Development, and received the Perry E. Foote Eminent Scholar Chair, Endowed Professorship, in 2019. Dr. Bulitta’s research focuses on combating multidrug-resistant bacterial ‘superbugs’ which present one of the three most serious threats to human health.

His mission is to optimize patient therapies and innovative drug development by providing a focal point for translational research in infectious diseases and related areas, and to serve as an internationally-leading, interdisciplinary, collaborative program for translational research.

Dr. Bulitta’s vision is to provide novel solutions and great hope for patients with serious, life-threatening infections by developing new safe and effective therapies. These are informed at the molecular level by an innovative combination of mechanistic, in vitro, animal and quantitative approaches to rationally optimize outcomes in patients. His highly collaborative research program leverages latest pharmacological, microbiological, biochemical and computational approaches. This creates unique translational insights that enable novel therapies and dosing strategies, as well as the design and development of new drugs. We work hard so that we can say “we have an effective therapy for you” when you most need it.

He won 26 peer-reviewed grants (15 as PI) from the NIH, FDA, the Australian equivalents of NIH and NSF, as well as 30 collaborative projects with pharmaceutical industry (total: $35M, 18M active). Dr. Bulitta published 140 peer-reviewed papers and contributed to over 97 phase I-IV clinical trials. He reviewed for several NIH study sections and received 23 awards since 1998. These include the Giorgio Segré Prize 2010 for distinct contributions in the field of pharmacokinetics and pharmacodynamics by the European Federation for Pharmaceutical Sciences (EUFEPS) and the 2012 ASCEPT Denis Wade Johnson & Johnson New Investigators Award. Dr. Bulitta created the Translational Clinical Pharmacology course (PHA6133). He is the creator and developed of the SADAPT-TRAN package that greatly facilitates the development of systems pharmacology models in the S-ADAPT population modeling package.

Folakemi Odedina

Folakemi Odedina Ph.D.

Professor

Folakemi Odedina works on the development of a predictive behavioral model of prostate cancer disparities among Black men and the implementation of cost-effective, community-based intervention programs in minority and underserved communities.

Odedina’s research program focuses on the predictors of health disparities and cost-effective, community-based behavioral interventions to improve the health of Black men. She has directed more than 20 research projects, including: (1) the Florida A&M University Center for Minority Prostate Cancer Training and Research (CMPC), which comprises a trans-disciplinary team of clinical, behavioral and basic scientists; and (2) a landmark Department of Defense prostate cancer research project which accrued over 3,000 Black men in Florida. Her initiatives include the Men’s Health Initiative and the Black Men’s Health Consortium in Florida.

Odedina’s research traverses across the world with an international consortium group in Africa, Caribbean Islands, Europe and the United States. She has received numerous awards for her work, including the 1st American Society of Health-Systems Pharmacy/ Association of Black Health-System Pharmacists Leadership Award for Health Disparities (2009); American Association for Cancer Research – MSI Faculty Award in Cancer Research (2007, 2002, 1998); US Fulbright Scholar award (2006 – 2007); Role Model Award Citation by Minority Access Inc (2005); and Association of Black Health-system Pharmacists Research and Publication Achievement Award (2004). She is also noted in Who’s Who in America and Who’s Who in Science and Engineering publications. Odedina currently serves on several international, national and state initiatives for cancer.

Joshua Pullo

Joshua Pullo Pharm.D.

Clinical Lecturer
Janel Soucie

Janel Soucie Pharm.D.

Clinical Lecturer And Regional Coordinator Orlando

Dr. Soucie received her Pharm.D. from Nova Southeastern University College of Pharmacy. She completed a Primary Care Pharmacy Residency at Advent Health Celebration. She has worked as a staff pharmacist in both the inpatient and community pharmacy settings. She initiated and managed an Anticoagulation Management Service at Florida Hospital East Orlando where she received the Model of Excellence award. More recently, she worked as a Clinical Pharmacist Specialist in Anticoagulation at the Orlando VA Medical Center for several years. Dr. Soucie has been Adjunct Clinical Faculty for University of Florida for many years, serving as a preceptor for pharmacy students. She has also been a pharmacy residency preceptor at the Orlando VA Medical Center.

Lisa Vandervoort

Lisa Vandervoort Pharm.D.

Clinical Lecturer And Regional Coordinator Orlando

Lisa Vandervoort received her Doctor of Pharmacy degree from the University of Florida College of Pharmacy in 1995 and completed a Pharmacy Practice Residency at Shands Hospital at the University of Florida in 1996. She spent 10 years as the Clinical Specialist in Infectious Disease/Internal Medicine at Orlando Regional Medical Center. For the past 10 years Dr. Vandervoort has been at the University of Florida both at the Orlando Campus and with the WPPD program. Her primary interests include student development, pharmacokinetics, infectious disease and internal medicine.

Jacksonville Campus

Carol A Motycka

Carol A Motycka Pharm.D., BCACP

Clinical Associate Professor

Dr. Carol Motycka graduated from the University of Florida with her Pharm.D. and completed a residency in Ambulatory Care at Florida Hospital in Orlando. After practicing at Florida Hospital for several years, Motycka joined the University of Florida to help build the College of Pharmacy program in Jacksonville. She is board certified in Ambulatory Care has completed fellowships in both leadership and education. Motycka has been published in multiple academic and clinical journals and has provided over 100 presentations in the field. She has received awards on the state and national level for her teaching, research, and leadership. Motycka is a strong advocate of the profession of pharmacy and serves the profession through public relations events in her community and professional organizations where she has served in multiple capacities including Speaker of the House for the Florida Pharmacy Association and President of Duval County Pharmacy Association. As assistant dean of the University of Florida College of Pharmacy Jacksonville Campus, Motycka spends her time teaching, completing research, advising and administrating.

Robin Moorman Li

Robin Moorman Li Pharm.D., BCACP, CPE

Clinical Associate Professor And Assistant Director

Robin Moorman Li is currently a Clinical Associate Professor with the University of Florida College of Pharmacy and serves as the Assistant Director of the Jacksonville campus. She received her Bachelor’s degree from Kansas State University in 1996 and completed her Doctor of Pharmacy at University of Kansas in 2000. Moorman Li completed a primary care residency at University of Mississippi Medical Center in 2001, and became a pharmacy practitioner with Shands Jacksonville from 2001 to 2008 where she created a pharmacist driven pain management clinic in a primary care clinic. In 2003, she began teaching part time with the University of Florida College of Pharmacy and transitioned to full time faculty with the College in 2008. Moorman Li practiced at the River Garden Hebrew Home for the Aged from 2008-2016 and is now practicing at UF Health Jacksonville in the Ambulatory Pharmacist ran Pain Management Clinic and also in the Center for Pain Management at UF Health Jacksonville.

Anthony M Casapao

Anthony M Casapao Pharm.D., M.P.H.

Clinical Assistant Professor

Anthony M. Casapao received his Doctor of Pharmacy degree from Wingate University in Wingate, North Carolina. He then pursued post-graduate training at St. Vincent’s Medical Center in Jacksonville, Florida, by completing an American Society of Health-System Pharmacists, or ASHP, -accredited pharmacy practice residency. Casapao continued his post-graduate training at University of Pittsburgh Medical Center in Pennsylvania, completing an ASHP-accredited specialty practice residency in infectious diseases. Upon completion of his residency, he maintained his interest in infectious diseases and pursued an American College of Clinical Pharmacy peer reviewed pharmacotherapy fellowship in infectious diseases and health outcomes. After achieving five years post-graduate training, Casapao served as an assistant professor in the department of pharmacy practice at Husson University School of Pharmacy in Bangor, Maine. Casapao joined the University of Florida in October 2017, as a clinical assistant professor in the department of pharmacotherapy and translational research.

Eric F Egelund

Eric F Egelund Ph.D., Pharm.D.

Clinical Assistant Professor

After completing his Pharm.D. at the University of Florida College of Pharmacy, Dr. Egelund enrolled in the Ph.D. program at the University of Florida. Dr. Egelund completed his graduate studies in the Department of Pharmacotherapy and Translational Research under the mentorship of Dr. Charles Peloquin, director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) in Gainesville. Currently Dr. Egelund is a Clinical Assistant Professor at the College of Pharmacy’s Jacksonville campus. In addition to this role Dr. Egelund works part-time at Walgreens and volunteers at HIV clinics when time permits.

Kelsey Cook

Kelsey Cook Pharm.D., BCPS

Clinical Assistant Professor

Kelsey Cook, Pharm.D., received her B.S. from the University of Maryland and her Pharm.D. from the University of North Carolina. She completed a PGY1 Pharmacy Practice Residency at Dell Seton Medical Center in Austin, Texas and a PGY2 Clinical Pharmacogenomics Residency at the University of Florida in Gainesville, Florida. Dr. Cook joined the University of Florida College of Pharmacy, Jacksonville campus as a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research in 2019. In her role, she supports the implementation of pharmacogenomics at Nemour’s Childrens Specialty Care. Dr. Cook is a board-certified pharmacotherapy specialist. Her research interests include clinical implementation of pharmacogenomics and pharmacogenomics in pediatrics. ​

Nathan D Seligson

Nathan D Seligson Pharm.D.

Clinical Assistant Professor

Dr. Seligson earned his Doctor of Pharmacy degree from the University of South Florida in 2015 prior to completing a pharmacy practice residency in 2016. Dr. Seligson then completed a post-doctoral fellowship in translational hematology/oncology focused on precision medicine in sarcoma.

Dr. Seligson is now a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research. His clinical practice includes activities as a clinical pharmacogenomics specialist and hematology/oncology research scientist at Nemours Children’s Specialty Care in Jacksonville, Florida.

Dr. Seligson has been published in as first author in leading journals including: JAMA Open Network, The Oncologist, and Oncotarget. His current research includes work to better understand cancer biology and tumor evolution in order to provide actionable molecular subtyping and pharmacogenomic therapy guidance in sarcoma.